U.S. Basic Materials Stock News

General Mills (GIS) shares traded steadily on Tuesday, shrugging off recent volatility seen in the broader food sector. Investors are considering the company’s long-term fundamentals, even as year-to-date returns show a decline of nearly 24 percent. See our latest analysis for General Mills. After a strong start to the year, momentum for General Mills has faded as the share price has slipped nearly 24% year-to-date, with a total shareholder return of about -29% over the past 12 months. Recent...

ZoomInfo recently unveiled Copilot Workspace, an AI-powered execution engine designed to unify and automate go-to-market operations for sales, account management, and customer success teams by integrating CRM systems and providing real-time, actionable insights. This launch addresses high industry inefficiencies and fragmented toolsets, positioning ZoomInfo to help revenue teams streamline demand generation as AI transforms buyer engagement practices. We'll examine how Copilot Workspace's...

Thinking about what to do with Netflix stock? You are definitely not alone. Whether you have ridden the incredible wave up—Netflix shares have soared 72.2% in the past year and 404.6% over three years—or you are just now considering if you should jump in at $1,215.35, there is a lot to consider. Year-to-date, the stock is up a remarkable 37.1%, so naturally, everyone is asking the same question: does this momentum have room to run, or are expectations starting to get a little ahead of...

Thinking about what to do with Nebius Group stock? You are not alone, especially when a company posts a jaw-dropping 320.0% year-to-date gain. For investors weighing the next move, the story here is anything but boring. Just last week, shares climbed another 8.9%, and if you zoom out to the last month, they are up more than 41.7%. Those numbers have everyone paying attention, whether you have been watching for a while or just heard the name for the first time. What is behind all this...

Terex stock recently saw some upward movement as President Donald Trump struck a more conciliatory tone on U.S.-China relations. This shift in rhetoric brought broad relief for industrial names like Terex and countered trade-related worries. See our latest analysis for Terex. After a tough start to the year, Terex has recently regained some momentum, supported both by a friendlier macro backdrop and the appointment of industry veteran Srikanth Padmanabhan to its board. While the 21.7%...

Conagra Brands (CAG) is back under the spotlight after analysts highlighted the company’s strengths in reaching value-focused shoppers, especially in tough times. Investors are also eyeing its strong dividend yield as a potential draw. See our latest analysis for Conagra Brands. Conagra’s year has been a test of resilience, with new leadership announcements, a completed share buyback, and fresh product spotlights not enough to offset pressure on results. Despite active moves, shares have slid...

Celldex Therapeutics (CLDX) has seen renewed interest as excitement builds over barzolvolimab's outlook in chronic urticaria, along with broader positive momentum across small and mid-cap biotech stocks. See our latest analysis for Celldex Therapeutics. Celldex's renewed buzz has helped power an impressive rebound, with a 15% share price return over the past 90 days highlighting the strength of recent momentum. While the 1-year total shareholder return remains negative at nearly -10%,...

In recent news, Google Cloud and Accenture announced an expanded strategic alliance to deliver Gemini Enterprise agentic AI solutions, advancing the integration of generative AI and multi-agent systems into client workflows across sectors such as hospitality, telecommunications, and healthcare. This collaboration highlights Accenture's growing emphasis on AI-driven transformation and is further supported by internally aligning leadership through the appointment of Shaheen Sayed as Chief...

Fox (FOXA) is grabbing investor attention after announcing a new partnership with Mobian, aiming to elevate its digital advertising game. The collaboration focuses on harnessing AI to create smarter and more measurable ad experiences across Fox’s vast media holdings. See our latest analysis for Fox. Fox’s new partnership builds on a year of real momentum for shareholders. Despite short-term volatility, the 12-month share price return sits at an impressive 18.6%. Long-term holders have seen a...

Banner (BANR) is preparing to announce its Q3 2025 earnings, and investor interest is picking up as analysts have raised earnings estimates for both 2025 and 2026. This development comes as expectations grow for improvements in key financial metrics. See our latest analysis for Banner. Shares have seen renewed interest ahead of the earnings announcement, with a 3.78% one-day share price gain recently helping to offset a slower patch. However, total shareholder return over the past year...

If you are watching NextEra Energy right now and wondering whether it is the right moment to jump in or hold your shares, you are not alone. The stock has been on the move. Over the past month, it gained an impressive 18.1%, and it is now up by 18.2% for the year to date. Even if you zoom out, the stock’s five-year return sits at 27.6%. After a relatively modest gain of 5.4% over the past year, this renewed momentum has caught the eye of investors refocusing on the renewables space. Part of...

POET Technologies (NasdaqCM:POET) just wrapped up a significant private placement, raising $75 million from a single institutional investor while issuing both shares and warrants. This move comes at a time when the market is already focused on the company’s deep negative margins and ongoing losses. See our latest analysis for POET Technologies. After trending lower for much of the year, POET Technologies has seen a sharp swing in momentum lately, with a 72.7% 1-month share price return...

If you are staring at Elevance Health’s stock chart and wondering what to do next, you are not alone. With the share price closing recently at $350.48, this is a stock that has gotten the attention of plenty of investors, both for its rollercoaster moves and for what might be coming next. Over the past month, Elevance has rallied 12.4%, even though it dipped slightly this past week, down 2.0%. Year-to-date, it is still slightly in the red at -4.2%, and looking at the past year, the stock is...

In the past week, Cboe Global Markets secured regulatory approval from the Australian Securities & Investments Commission to operate a stock listings market in Australia, enabling new competition for IPO listings in the region. This move marks a major step in Cboe’s global expansion, allowing the company to directly challenge the Australian Securities Exchange and broaden its presence in Asia Pacific financial markets. We'll explore how gaining access to Australia’s listings market could...

Thinking about Zoetis and whether to hang on, buy more, or move on? You are far from alone; the stock has made some surprising moves lately and investors everywhere are asking the same questions. After a modest 0.5% gain over the past week, Zoetis is still sitting well below its recent peaks, down 3.2% over the last month and trailing by a hefty 24.5% versus this time last year. It's clear the risk perception around Zoetis has changed, perhaps spurred on by shifting sentiment in the broader...

Molina Healthcare (MOH) shares saw a modest uptick today, recouping some losses from the past week. Investors appear to be weighing recent market movements in comparison with the company's longer-term trends and steady growth in annual revenue. See our latest analysis for Molina Healthcare. After a choppy start to the year, Molina Healthcare’s 1-month share price return of nearly 8% hints at renewed optimism, even as the stock’s year-to-date return stands deep in the red. The 1-year total...

Minerals Technologies Inc. recently reported strong second quarter 2025 results, with an 8% sequential increase in revenue and a 36% rise in earnings per share, driven by growth initiatives such as new product lines and facility expansions. An interesting aspect of these results is the company's expectation that ongoing investments could add US$100 million in revenue, while maintaining focus on sustainability and operational efficiency despite market challenges and tariff impacts. We'll...

Criteo (NasdaqGS:CRTO) has just unveiled a multi-year partnership with DoorDash to expand advertising opportunities across the DoorDash marketplace, with a particular focus on grocery and convenience channels. The collaboration is designed to broaden how brands and agencies connect with consumers at the point of purchase. See our latest analysis for Criteo. Even with the buzz from Criteo's DoorDash partnership, the stock has faced definite headwinds, posting a -49% share price return...

CorMedix (CRMD) shares have seen distinct swings over the past month, prompting investors to revisit the company's fundamentals. Changing sentiment in biotech has played a role. CorMedix’s recent numbers offer relevant valuation context. See our latest analysis for CorMedix. CorMedix’s share price has cooled off after a strong run, with a 1-month share price return of -18.55% offsetting some of the enthusiasm from its robust 28.22% year-to-date gain. Despite recent volatility, the company’s...

TechnipFMC (FTI) has seen shares dip around 9% over the past month. This comes despite steady revenue and net income growth over the past year. Investors seem to be weighing recent market sentiment alongside longer-term returns. See our latest analysis for TechnipFMC. Despite some recent selling pressure, TechnipFMC’s 30-day share price return of -9.7% comes after a strong run so far this year. Its 21.7% year-to-date share price gain and robust 37.7% total shareholder return over the past...

If you have been eyeing Hims & Hers Health stock lately, chances are you have noticed just how much this name has grabbed the market’s attention. Whether you are considering jumping in or debating whether to hold on after a monster run, you are not alone. The conversation around Hims & Hers is louder than ever. There is good reason for that: shares have skyrocketed 114.4% since the start of the year and are up a staggering 1,130.5% over the last three years. That is the kind of performance...

Trying to figure out what’s next for Arista Networks? You’re not alone. Whether you’re already holding shares or just eyeing this tech heavyweight from the sidelines, there’s plenty to consider. With Arista’s stock closing recently at $138.79, it’s hard to ignore its eye-popping track record. The stock is up more than 900% over the past five years and has jumped 41.5% in just the last year. Those kinds of long-term gains can make anyone wonder if the momentum will continue, especially when...

On October 14, 2025, Realty Income Corporation announced the appointment of Kim Hourihan to its Board of Directors, increasing the board to eleven members and adding her extensive global real estate investment expertise. This appointment is being highlighted as a milestone for corporate governance, positioning Realty Income to further strengthen its leadership amid ambitious global expansion and diversification initiatives. We’ll examine how Kim Hourihan’s leadership background could shape...

Vertex Pharmaceuticals (VRTX) has continued to attract investor attention. Recent movements in its share price prompt a closer look at the company’s fundamentals and growth outlook. Over the past month, VRTX shares have climbed 4%. See our latest analysis for Vertex Pharmaceuticals. VRTX's recent 4% share price climb has added a spark to a year marked by volatility, with momentum beginning to return after a difficult patch. Despite a modest year-to-date advance, the company’s one-year total...